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have been reported in different studies (5, 6) . Additionally, minimally invasive surgical approaches help not only in a reducing postoperative bleeding but also in preserving physiology and respiratory mechanics, guaranteeing good exposure of heart and great vessels (7) . At the same time, anesthesia and analgesia strategies must help in the safe planning of the intraoperative workup and effective postoperative pain control. Therefore, a less invasive anesthesia should influence rapid recovery of the patient.
The aim of our study was to compare the impact on the outcomes of 2 left ventricle assist device (LVAD) implantation approaches, the minimally invasive approach associated with paravertebral block (PVB) (mini-invasive group) and the standard surgical approach associated with general anesthesia (GA) (invasive group). The primary end points of the study were to detect the differences in intraoperative and postoperative hemodynamics, mechanical ventilation, recovery and discharge times as well as mortality. The secondary end points of the study were to detect differences in the efficacy of the anesthesia on pain control, fast mobilization and pulmonary infections.
Materials and methods
Sixty-eight patients with HF refractory to maximal medical therapy were supported with LVAD in our center from A pilot study on the efficacy and safety of a minimally invasive surgical and anesthetic approach for ventricular assist device implantation VAD = ventricular assist device; Redo = reintervention; EF = ejection fraction; sPAP = systolic pulmonary arterial pressure; CBP = cardiopulmonary by-pass; ECMO = ExtraCorporeal Membrane Oxygenation; BTT = bridge to transplantation, BTC = bridge to candidacy; DT = destination therapy; RV = right ventricle; MOF = multiorgan failure.
Introduction
January 2010 to August 2016 (Tab. I). Informed consent was obtained from all individual participants included in the study. Thirty-six patients were assisted with the Jarvik 2000 (Jarvik Heart, New York, NY) and 32 patients with HVAD (HeartWare International, Inc., MA, USA). The policy at our center is to implant the Jarvik 2000 LVAD as DT or BTC and HVAD as BTT or BTC. The rationale behind this choice derives from the simplicity that the Jarvik-2000 users have in managing antithrombotic therapy and the retroauricular driveline during time at home.
The high ministernotomy (MS) associated with left minithoracotomy (LMT) surgical approach was chosen in 28 patients (22 HVAD and 6 Jarvik 2000) , while bilateral minithoracotomy (BMT) was used in 13 patients (3 HVAD and 10 Jarvik 2000) (mini-invasive group). Left thoracotomy (LT) was chosen in 17 patients (all Jarvik 2000), while sternotomy was used in 10 patients (7 HVAD and 3 Jarvik 2000) (invasive group). The first 5 LVAD implantations for each model were not considered in the study to avoid the bias related to the learning curve. Afterwards, we performed a time-evolution in the implantation technique, from left thoracotomy, to full sternotomy, to the combination of the LMT to MS, as well as the association with BMT.
All the patients belonging to the mini-invasive group received mild general anesthesia associated with a paravertebral block (PVB), while all the patients in the invasive group received a standard general anesthesia (GA). According to our protocol ( Fig. 1) , in unstable patients an extacorporeal membrane oxygenator (ECMO) was used to stabilize hemodynamics, and LVAD implant indications were given. To reduce the risk of bleeding, the treatment of ECMO was performed with low-molecular-weight heparin (LMWH), and consequently a possible 12 hours suspension before surgery. We gave the name of "fast-ECMO" to this type of approach. PerioperativeECMOs were implanted in the event of poor toleration at heart manipulation.
Anesthesia -paravertebral block
In the operating room (OR), after light sedation (intravenous [IV] 1 mg midazolam), PVB was performed in the awake patient in the lateral or sitting position by a skillful anesthesiologist. After local anesthetic infiltration of the skin and muscular plane (5 mL lidocaine 2%) a Tuohy 17-gauge needle was inserted at level of T4-T5, 3 cm on the left side of the spinous process of the T4 dorsalis vertebra. In the case of BMT, the procedure was repeated on the right side of the spinous process of the T2 dorsalis vertebra. Identification of the paravertebral space was done by loss-of-resistance technique, without ultrasound or nerve stimulator, first identifying the transversus process with a reviewed technique (8) .
When the paravertebral space was reached, an epidural catheter (19-gauge) was inserted and left at 2 cm beyond the tip of the needle. A subcutaneous tunnel was made to prevent accidental removal of the catheter. A cumulative dose of 20 mL of 0.5% Ropivacaine (100 mg) was done for intraoperative analgesia (10 mL at minithoracotomy closure). Induction of GA was performed with doses of sodium thiopental (4 mg/kg), fentanyl (200 mcg total dose), and rocuronium (0.6 mg/kg). A double-lumen tube was inserted for endotracheal intubation and mechanical ventilation was performed with a protective strategy (tidal volume 8 mL/kg, respiratory rate 10 b/min, PEEP: 4 cmH2O). Anesthesia was maintained by propofol (3-5 mg/kg per hour) and Remifentanil infusions (0.05-0.1 mcg/kg per minute). At the end of the surgical procedure, remifentanil and propofol infusion were suspended and extubation was performed, if possible in a short time in the OR, in order to guarantee afterload reduction of the right ventricle (RV). Postoperative pain control was ensured by 0.2% ropivacaine continuous infusion at a speed of 5 mL/h by paravertebral route, intravenous continuous infusion (elastomeric device) 3 mcg/h of Sufentanil, and intravenous analgesics upon patient request. A PVB catheter was maintained for 48 hours and removed afterwards.
General anesthesia
As premedication, flunitrazepam, 2 mg, was administered orally 90 minutes before surgery. On arrival in OR, a large-bore peripheral venous catheter and a radial artery catheter were inserted. After baseline monitoring, IV anesthesia was induced, following preoxygenation, over a period of 10 minutes with thiopental, 1.5 mg/kg, fentanyl, 5 mcg/kg, and rocuronium, 0.6 mg/kg. Endotracheal intubation was performed 5 minutes after administration of rocuronium, and controlled ventilation with oxygen/air (FIO2 = 0.6) was instituted to normocapnia (end-tidal PCO2 35 to 40 mmHg). After induction of anesthesia, a central venous catheter was inserted in the right internal jugular vein. In this phase, anesthesia was maintained with continuous inhalation of sevoflurane (0.9%) and sufentanil (0.1 mcg/kg per hour). Before LT and/or sternotomy IV continuous infusion of propofol at a rate of 4-6 mg/kg per hour was started. During and after the incisions, both groups were supplemented with intermittent boluses (5 mcg/kg) of fentanyl (up to a total maintenance dose of 30 mcg/kg) received prophylactically to blunt brief but intense periods of pain and autonomic stimulation (sternal splitting and spread, aortic mobilization, clamping and declamping, and sternal-thoracotmy closure). Each patient received 0.025 mg/kg of pancuronium every hour for muscle relaxation and mechanical ventilation during surgery. Propofol infusion was stopped at the end of surgery and extubation was performed if possible in the operating room (OR). Postoperative pain control was assured by intravenous continuous infusion (elastomeric device) 3 mcg/h of sufentanil at the first 48 postoperative hours and intravenous analgesics upon patient request.
Common anesthetist strategies
In both modalities, the depth of anesthesia was monitored by the bispectral index of the EEG (BIS) (BIS ® monitor; Aspect MS). A Swan-Ganz catheter and a transesophageal echocardiography (TEE) probe were inserted for monitoring RV and left ventricular (LV) function, and LVAD inflow cannula position. The Visual Analog Scale (VAS) was used to assess the quality of analgesia and data were collected at 1, 6, 24 and 48 hours postoperatively.
Surgical technique

Minimally invasive approach
LMT (almost 5 cm) was performed through the fifth intercostal space, followed by the opening of the pericardium and exposure of the heart apex ( Fig. 2) . The insertion site of the LVAD inflow cannula was marked on LV, after TEE assessment, to be parallel to the interventricular septum and pointing toward the mitral valve. The LVAD sewing ring was secured to LV by using interrupted pledgeted 2-0 polypropylene sutures and sealing the suture line by applying BioGlue (CryoLife). An IV dose of 5,000 IU of heparin was administrated and therefore the pump inserted. After de-airing and, in TEE, ensuring that the LVAD was housed in the correct position, the sewing ring was fixed around the inflow cannula. The driveline was then tunneled subcutaneously to its exit point at the left lower abdominal quadrant in the case of an HVAD implant, or toward the left or right retroauricolar space in the case of a Jarvik 2000 implant.
Next, an upper high MS ( to the second intercostal space) or right anterior minithoracotomy (RMT) (4-5 cm) was performed, the pericardium was opened to expose the aorta and pulmonary artery. The outflow LVAD vascular graft was tunneled and stretched underneath LMT to MS or RMT, in order to measure and next cut the right length without kinking or overstretching it. A side clamp was placed on the ascending aorta. The outflow graft was sewn to the aorta with 4-0 polypropylene suture, and the sutures were reinforced with BioGlue surgical adhesive. Once the de-airing was completed, we released the outflow graft cross clamp and gradually increased pump speed to achieve the desired flow. The check of RV function was done by TEE and dosages of inotropes modified to guarantee good hemodynamic stability.
Standard surgical approach
LT (almost 14-18 cm) was performed through the fifth intercostal space, followed by the opening of the pericardium and exposure of the heart apex. The descending aorta was isolated and used as the outflow graft anastomosis site. The insertion of the inflow VAD cannula was performed as previously described. In the case of full sternotomy, the outflow graft anastomosis was performed on the ascending aorta.
Data recording
Time from the entry into OR to the completed PVB was measured as anesthesia-related time. Sensation was assessed by the pinprick test at 2-minute intervals to document the dermatome levels blocked (mini-invasive group). Time from entry into OR to insertion of the endotracheal lumen tube was recorded as anesthesia-related time in the case of GA (invasive group).
Patients were considered ready for surgery when a complete loss of pinprick sensation was recorded on the operation site. Surgery times were recorded in both groups. The first need for analgesics was recorded, as well as the pain score at this time and the frequency of administration. The mean systemic pressure and heart rate during surgery were monitored. The duration of anesthesia was considered to be the time from the entry in the OR to the suspension of infusion of anesthetic agents in the postoperative period. The time to first mobilization was considered to be the postoperative day (POD) when active mobilization, such as on an exercise bike, was possible.
Statistical analysis
Mini-invasive group
We conducted a retrospective study on data prospectively collected in our LVAD database. Differences in demographic, anesthetic, surgical, recovery, and postoperative data in groups were compared with the independent samples t-test for continuous data and the chi-square with Fisher's exact test for categorical data. To account for the high number of variables considered in comparing mini-invasive and invasive groups, p-values were adjusted for multiplicity using the Holm correction (9). All categorical data are presented as number (number, %) and continuous data as mean ± SD. This is a pilot study aimed at exploring the proposed hypotheses; the larger the differences between proportions or mean values and, respectively, the more narrow confidence limits and standard deviations, the smaller the size of samples necessary to demonstrate a significant difference with a stated p value and confidence level. Therefore, the observed differences between techniques were used to figure out the required sample sizes of possible future studies with a sufficient statistical power. The assumptions used in computation were: alpha = 0.05 (2-sided); power = 0.7; observed mean value and standard deviations of the continuous variables or proportion differences of the categorical variables, and equal size of the samples as in this pilot study. Analyses were performed using the R system for statistical computing (10) and the gMCP libraries (11).
Results
Patient characteristics and surgical data were comparable in both groups. The unique significant difference was the LVAD indication (Tab. II).
Intraoperative outcomes
Intraoperative outcomes are shown in Table III . "Fast-ECMO" was necessary in 10 patients in the mini-invasive group and 7 patients in the invasive group. Additionally, 7 perioperative ECMOs were implanted, due to poor toleration at heart manipulation (3 in the mini-invasive group and 4 in the invasive group). In 4 patients an associated procedure was necessary (aortic valve replacement and pulmonary artery endoarterectomy) (3 in the mini-invasive group, and 1 in the invasive group).
Time to perform anesthesia was significantly longer when applying PVB (43 ± 9 minutes versus 26 ± 17 minutes). On the contrary, duration of surgery and anesthesia resulted significantly shorter in the mini-invasive group (p<0.05). Heart rate, systemic pressure, and all the adverse anesthesia related events were comparable in both groups. The BIS % observed was significantly higher in the mini-invasive group (p<0.0032).
Primary and secondary end points
Primary and secondary end points are shown in Table  IV . Almost half the patients operated on with the minimally invasive technique and PVB were extubated in OR (22) (p<0.0001). The duration of mechanical ventilation was significantly shorter in the PVB group (p<0.0001). The fact that ICU stay (p<0.0001) and duration of intravenous inotropic support (0.02) are found to be significantly shorter in the mini-invasive group resulted in a significant reduction in hospitalization (p<0.0001) and a significantly more rapid mobilization of the patient (p<0.002).
In 55 patients (80%) the LVAD implantation was performed off-cardiopulmonary bypass (24 on ECMO support: 10 in the invasive group and 14 in the mini-invasive group) (Tab. I). Four patients in the mini-invasive group and 5 patients in the invasive group required RVAD because of perioperative RV failure (defined according to INTERMACS registry definitions of adverse events) after LVAD implantation (p = 0.7).
The pulmonary infections were also statistically comparable, although a higher incidence was encountered in the invasive group (p = 0.125).
Thirty-day mortality was higher in the invasive group than in the mini-invasive group, although not significant (p = 0.05). The overall survival of the population was of almost 60% at 3 years of follow-up (Fig. 3A) , while survival was almost significantly higher in the mini-invasive group (almost 70% vs. 50% in the invasive group, p = 0.05) (Fig. 3B) . When survival is considered separately and compared according to the different approaches (invasive vs. mini-invasive), the results are statistically similar (HVAD p = 0.59; Jarvik-2000 p = 0.16), despite the fact that in both devices the curves of the mini-invasive approach were positioned at higher values for almost all FUs (Figs. 4A and B) . 
Other clinical outcomes
No serious adverse events related to the procedure were identified during the study (Tab. III), despite the 3 cases of slow awakening in the invasive group.
In the mini-invasive group, a reduced number of patients transfused with blood units and a reduced number of units transfused for each patient, was observed. The difference did not reach statistical difference (p = 0.264 and 0.097, respectively) (Tab. IV). A significant reduction in the transfusion of plasma and platelets units was recorded in the mini-invasive group (p<0.03 and 0.0004, respectively).
As far as renal function and stroke are concerned, no significant differences were observed within the groups. A total of 15 patients were successfully transplanted, 9 in the miniinvasive group and 6 in the invasive group (Tab. IV).
Three patients in the mini-invasive group died at POD 30: 1 of hemorrhagic stroke, 1 for bowel ischemia, and the last 1 for sepsis. Of the 8 patients in the invasive group, 3 died due to sepsis, a further 3 to multiorgan failure and 2 to right ventricle failure.
No significant differences were observed in the first administration of analgesic agents or in the pain score at this time, nor in the frequency of administration in the subsequent 2 PODs (Tab. IV). Despite this, we noticed a lower analgesic requirement in the early postoperative hours, which increased over the subsequent days in the invasive group versus a more constant demand in the mini-invasive group (Tab. V).
Estimation of sample size
The estimation of the sample size is provided in Table VI . We calculated the required number of patients to recruit in order to render the outcomes statistically meaningful. To achieve a power analysis of 70% and an alfa value of 0.05, a small sample size is required to show significance in the efficacy of the PVB procedure associated with a minimally invasive approach for extubation in the OR (25 patients), reduced mechanical ventilation time (30 patients), reduced in-hospital stay (30 patients), and time to first mobilization (42 patients). On the other hand, for variables like duration of inotropic support (87 patients), postoperative RVAD support (1,414 patients), discharge at home (188 patients), death (130 patients), and finally pulmonary infections (141 patients), a larger sample size is necessary to demonstrate the efficacy (Tab. VI).
Discussion
Given the shortage of valid organs available, patients arrive more frequently in our hospitals in cardiogenic shock, refractory to maximum medical therapy, and requiring MCS in a short period of time. These patients often present poor general conditions. All these factors lead to emergent heart transplantation with challenging results for the patient, due to the high risk of primary graft-failure or to the patient being excluded from the heart transplantation wait list. For this reasons, the LVAD has increasingly become the main solution for such patients.
The aim of our study was to compare the impact of 2 different approaches as an integral part of the LVAD treatment: a minimally invasive surgical approach associated with PVB versus the standard surgical approach associated with classic GA. The primary end points of the study were to detect the differences in perioperative and postoperative hemodynamics, mechanical ventilation, recovery and discharge times as well as mortality. The secondary end points were to detect differences in the efficacy of the anesthesia in pain control, fast mobilization and pulmonary infections as a consequence of prolonged mechanical ventilation and depressed respiratory function.
Data confirming that the VAD therapy leads to remission of pathologies and normalization of the clinical condition have been published (12) (13) (14) . Given the frailty of these patients, an impairment of hemodynamics, pulmonary and renal function is frequently observed (12) (13) (14) . Therefore, rapid recovery after LVAD implantation is very important. Key therapeutic intervention for frailty is exercise training (15), because it decreases hospitalizations and is also deemed to improve the clinically evident features of declining muscle mass strength (16, 17) . As a matter of fact, being trapped in bed would inevitably lead to the consequent loss of muscle mass, which compromises respiratory mechanics and prolongs wound healing. Several factors related to both the operative period (duration of surgery, prolonged intubation, blood cell transfusion) and the postoperative period (delayed mobilization and postoperative complications) may compromise the postoperative awakening (18) (19) (20) (21) . In order to achieve the desired results, both procedures, surgical and anesthetic, must ensure the fastest recovery possible, with the least possible impairment. Therefore, it is evident that the fast-track anesthesia may have an impact on rapid patient recovery and hospital discharge, along with an equally welcome reduction of in-hospital costs.
The 68 study patients were treated with 2 different anesthetic-analgesic and surgical approaches. The patients were comparable for all the risk factors studied except the LVAD implant indications. Our analysis shows a significant reduction of ICU and hospital stay in the mini-invasive group. Additionally, this new anesthetic approach in LVAD patients, namely PVB, more than halved the mechanical ventilation time and significantly reduced the duration of inotropic support. Other important evidence is the extubation data in the OR. In the mini-invasive group we extubated several patients soon after the procedure; this was not possible post GA. Early postoperative extubation allows a rapid transit from pressure-positive mechanical ventilation toward negative physiologic pressure with spontaneous breathing. This favors downloading of RV, frequently compromised in these patients. In fact, a lower incidence of postoperative RVAD support was observed in the mini-invasive group, although the difference was not significant. Furthermore, the inotropic support time in the patients in the mini-invasive group was significantly shorter, confirming the more prompt hemodynamic recovery of patients treated with PVB and the minimally invasive approach.
Postoperative pain control is an important issue because postoperative pain can depress the respiratory function, often resulting in complications such as pneumonia (22) . It is recognized that an adequate treatment of postoperative pain contributes significantly to the reduction of perioperative morbidity, assessed as incidence of postoperative complications, the length of stay and cost, especially in high-risk patients (ASA III-V) who undergo major surgery (23) . Actually, 9 patients in invasive group evidenced post-operative pneumonia, while this complication was recorded in 6 patients in the mini-invasive group. Although the incidence was higher in the invasive group, it did not reach statistical difference.
As far as postoperative pain control and the administration of analgesic agents is concerned, PVB has been reported to result in effective anesthesia, rapid recovery and good postoperative analgesia in cardiac surgery (24, 25) . In our study, good management was described when using both the anesthetic approaches. In fact, no significant differences were observed in the first administration of analgesic agents or pain score at this time, nor in the frequency of administration in the subsequent 2 PODs. However, we noticed lower analgesic requirements in the early postoperative hours, which increased in subsequent days in the PVB group versus a more constant demand in GA patients. We speculate that this increase matches with the PVB analgesic infusion suspension. Nevertheless, PVB also has a number of disadvantages, such as additional time required to perform the block, possibility of block failure, and need of expertise to perform the technique. Indeed, despite the fact that PVB was performed by skillful anesthetists, it required almost twice the amount of time when compared to GA anesthesia. In any case, no failure conversion or complications related to PVB, such as site hematoma, were observed in our series.
Finally, as far as 30-day mortality and long-term survival are concerned, from our data we can conclude that the minimally invasive approach allows an important reduction of inhospital mortality, and the long-term survival is comparable with that described in the literature, and probably even better considering that almost 80% to 90% of our patients are in INTERMACS I-II profile (3, 6, 12, 13, 20) . The survival of the patients treated with the mini-invasive approach presented better survival over time.
The principal weakness of our study is the dimension of the population. Given the small sample size, the study data are unlikely to have statistically meaningful results. On the other hand, pilot studies outline the differences in the results obtained with a poor size, providing a possible sample size population, to make the results meaningful in statistical terms. According to this pilot study, a series of 40 patients for each group would be sufficient to statistically show a difference between the 2 approaches for the majority of primary and secondary end points considered.
Conversely, a larger number of patients is required to test the significance for mortality, pulmonary infections, and RVAD temporal support. Finally, since good analgesic management was similar in both the procedures, the sample size required to test any difference for this issue would be infinity.
Conclusions
A minimally invasive approach associated with PVB may play a substantial role in VAD surgery by favoring faster recovery and shorter hospital lengths of stay, with benefits for survival. Thus, the choice of anesthetic treatment should be considered an integral part of LVAD treatment.
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